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Comparison of toxin-antitoxin expression among drug-susceptible 
and drug-resistant clinical isolates of Mycobacterium tuberculosis
Abstract
Introduction: Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB), is a significant global public health 
threat. Besides extensive multidrug resistance, MTB possesses several properties for long-term viability in the host as well as 
stress adaptation and resistance in harsh conditions. The role of toxin-antitoxin (TA) systems in disseminating and maintaining 
antimicrobial resistance in bacterial populations has also been demonstrated. This study aimed to evaluate differences in ex-
pression of MazEF (a well-known TA system) related genes (mazE3, mazF3, mazE6, and mazF6) amongst drug-susceptible and 
resistant MTB isolates in Iran.
Material and methods: A total of 20 confirmed clinical isolates of MTB including 10 drug-susceptible and 10 drug-resistant (nine 
MDR, and one XDR) species were included in this study. M. tuberculosis H37Rv was used as the standard strain. RNA extraction, 
cDNA synthesis, and relative quantitative real-time PCR were performed according to the standard procedures.
Results: Our analysis indicated significant enhanced expression of the mazE6 antitoxin gene in drug-susceptible isolates com-
pared to drug-resistant isolates and the standard strain. The expression of the mazF6 toxin gene was also increased in drug-sus-
ceptible isolates compared with the standard strain. In drug-resistant isolates, the expression levels of mazF3 and mazF6 genes 
were significantly higher than that in the susceptible isolates and the standard strain.
Conclusions: In this study, there was significant overexpression of mazE6 in drug-susceptible isolates. As well, mazF3 and F6 
were overexpressed in drug-resistant isolates when compared with the standard strain. The changes in expression levels of 
MazEF6 associated genes were greater than that of MazEF3 in both groups of isolates.
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Introduction
Mycobacterium tuberculosis (MTB), the caus-
ative agent of tuberculosis (TB), is a significant 
global public health threat [1]. According to World 
Health Organization (WHO) reports, there are 
more than 1.5 million TB-related deaths annu-
ally despite the extensive efforts to eradicate TB 
[2]. Multi-drug resistant (MDR) and extensively 
drug-resistant (XDR) TB are also major challenges 
in the elimination of TB [3]. 
MTB possesses several properties for its long-
term viability in hosts such as its special cell wall 
structure and metabolism [4]. Another important 
strategy for stress adaptation and resistance in 
harsh conditions (i.e. poor nutrition, oxidative 
stress, low pH, and hypoxia) is its Toxin-Anti-
toxin (TA) system [5-8]. The toxin molecule is 
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a stable protein and the antitoxin could either 
be a labile protein or non-coding RNA. During 
stressful conditions, the antitoxin is degraded and 
free active toxins interfere with essential cellular 
functions [5, 9].
MTB strains harbor several TA systems with 
MazEF being a well-known type [10]. MazEF 
consists of MazE (antitoxin) and MazF (toxin), 
and both components create a complex in normal 
conditions. This system has 10 loci in the MTB ge-
nome which are supposed to be effective in adapt-
ing to the environment, programmed cell death, 
cell cycle inhibition, persistence, and latency. 
MazF3, MazF6, and MazF9 inhibit mycobacterial 
growth. Also, they are important in expression of 
virulence factors. Further, MazF6 plays an essen-
tial role in cell survival [7, 9].
The role of TA systems in disseminating 
and maintaining antimicrobial resistance in 
bacterial populations has been demonstrated 
[11]. Moreover, previous studies indicate that 
mazE and mazF genes are differentially ex-
pressed in drug-susceptible and drug-resistant 
bacteria [12, 13]. This study aimed to evaluate 
differences in expression of MazEF related 
genes (mazE3, mazF3, mazE6, and mazF6) be-
tween drug-susceptible and drug-resistant MTB 
isolates in Iran.
Material and methods 
Bacterial strains 
A total of 20 confirmed clinical isolates 
of MTB including 10 drug-susceptible and 
10 drug-resistant (nine MDR, and one XDR) 
strains were included in this study [14]. Drug 
susceptibility testing (DST) and detection of 
resistance-determinant mutations amongst the 
isolates were also determined in a previous 
study [14]. M. tuberculosis H37Rv was used as 
the standard strain. This study was approved 
by the Ethics Committee of Ilam University of 
Medical Sciences (Register code: IR.MEDILAM.
REC.1395.34).
Total RNA extraction, cDNA synthesis 
and relative quantitative Real-time PCR
Total RNA of mycobacterial colonies was 
extracted by an RNA extraction kit (Thermo, 
Dreieich, Germany) for each strain. The Rever-
tAid First Strand cDNA Synthesis Kit (Thermo) 
was used for cDNA synthesis according to the 
manufacture’s protocol. Relative quantitative 
real-time PCR (RT-qPCR) was performed using 
SYBR Green Low ROX Master Mix (Amplicon, 
Brighton, UK) and specific primers (Table 1) 
[12, 14]. Reaction mixtures were made to 
a final volume of 25μL including 12.5μL of 2X 
SYBR Green master mix, 1μL of template cDNA 
(50 ng/μL), 0.4 pM of forward/reverse primers, 
and 9.5μL of ddH2O in a 0.2 mL PCR microtube. 
The PCR reactions were done according to the 
following protocol: 1 cycle of 95°C for 5 min, 
40 cycles of 95°C for 20 s, 58°C for 20 s, and 72°C 
for 30 s. To ensure the single amplicon produc-
tion, melting curve analyses were applied. The 
heat shock protein 65 gene (hsp65) was used as 
an internal control. The genome of H37Rv stan-
dard strain was used as the external control. All 
tests were performed twice.
Data and statistical analysis
For gene expression analysis, data were 
analyzed using the Line-Gene K software on the 
BIOER detection system using the Livak method 
(Livak. KJ, Analysis of relative gene expression 
data using real-time quantitative PCR and the 
2[-Delta Delta C(T)] method). SPSS 21 was used for sta-
tistical analysis. Data are represented as means 
± SEM and differences between groups were 
analyzed using t-test. P < 0.05 was considered 
as statistically significant. 
Results 
Our analysis indicated increased expression 
levels of mazE3 and mazE6 antitoxin genes in 
drug-susceptible isolates. It was negligible for 
mazE3 but enhanced expression of mazE6 was 
significant compared to drug-resistant isolates 
and the standard strain H37Rv (p < 0.01). In 
drug-resistant isolates, reduced expression of 
mazE3 gene was observed, but mazE6 exhibited 
Table 1. Sequences of primers used in relative quantita-
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non-significantly increased expression when 
compared with the standard strain (Figure 1).
Figure 2 shows mazF3 and mazF6 expression 
levels in the clinical isolates compared to the 
standard strain. The expression of mazF3 and 
mazF6 toxin genes were increased in drug-suscep-
tible and drug-resistant isolates compared with 
the standard strain. In drug-resistant isolates, the 
expression levels of both genes were significantly 
higher than that in the susceptible isolates and 
the reference strain (p < 0.05). The mean ± SEM 
of the relative expression changes are mentioned 
in Supplementary Table 1.
Discussion
Drug-resistant TB is still a serious global 
health problem. Besides extensive multidrug 
resistance, drug tolerance or persistence are oth-
er possible responses to antibiotic treatment of 
MTB infection [15, 16]. Stabilization in adverse 
conditions encountered in the host is one of the 
functions of TA systems and they are important 
in both the mycobacterial evolution and in the 
process of infection. MazEF induces a reduction 
in metabolic activity, persistence, and cell arrest 
via inhibition of protein synthesis leading to 
the bacteria being protected from antimicrobial 
agents [9, 17].
The present study was conducted to inves-
tigate mazE3, mazF3, mazE6, and mazF6 gene 
expression in drug-susceptible and drug-resis-
tant MTB isolates. We observed no significant 
increase  in the expression  level of mazE3 and 
mazF3 genes in susceptible isolates compared 
with the H37Rv standard strain (Figure 1 and 
2). In a study which was conducted by Zhao et 
al., similar mazF3 results in susceptible MTB 
strains were reported [12]. Also, no considerable 
changes in expression levels of MazEF encoded 
genes were previously described in susceptible 
Staphylococcus aureus isolates [13].
We found significant enhanced expression 
levels of mazE6 and mazF6 in susceptible iso-
lates when compared with the standard strain. 
However, overexpression of mazE6 was higher 
than mazF6 (Figure 1 and 2). The mazF6 upreg-
ulation and significant mazE6 downregulation 
in drug-susceptible MTB strains was reported 
in a previous study [12]. Regardless, a higher 
concentration of antitoxin may justify antibiotic 
susceptibility amongst our studied isolates. In 
other words, MazE6 can neutralize MazF6 toxin 
and prevent its endoribonuclease activity lead-
Figure 1. mRNA expression profile of mazE3 and mazE6 in drug
-susceptible and drug-resistant MTB clinical isolates compared to 
standard strain H37Rv. **p < 0.01
Figure 2. mRNA expression profile of mazF3 and mazF6 in drug
-susceptible and drug-resistant MTB clinical isolates compared to 
standard strain H37Rv. *p < 0.05; **p < 0.01
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ing to a normal microorganism metabolism and 
susceptibility to related antibiotics.
According to our results, no remarkable 
changes were observed in the expression lev-
el of mazE3 and mazE6 antitoxin genes in 
drug-resistant isolates in comparison with the 
standard strain (Figure 1). However, mazF3 and 
mazF6 were overexpressed significantly when 
compared to the drug-susceptible isolates and the 
standard strain. Overexpression of mazF6 was 
also higher than mazF3 (Figure 2). Reduced ex-
pression in antitoxin associated genes (mazE3, 
E6) and notable increased expression in both 
toxin genes (mazF3, F6) among drug-resistant 
strains was shown in previous research [12]. 
Accumulation of mazF3 and mazF6 may be due 
to various antibiotics and other exposures to 
stress of drug-resistant isolates. A high existence 
of MazF3 and MazF6 ribonucleases contributes 
synergistically to MTB growth inhibition and 
persistence and mediates resistance to anti-
microbial agents [5]. Moreover, these proteins 
facilitate MTB survival in macrophages, increase 
resistance to oxidative stress, cause nutrient 
deprivation, and may cause chronic infection 
[5, 7, 18].
Conclusion
In this study, upregulation of mazE6 in 
drug-susceptible isolates and mazF3 and F6 in 
drug-resistant isolates were observed when com-
pared to the standard strain H37Rv. Expres-
sion differences in MazEF6 associated genes 
were greater than in MazEF3-related genes in 
both groups of isolates. It seems that the role of 
MazEF6 in MTB persistence is greater than that of 
MazEF3. Knowing the role and expression level of 
the genes encoding TA systems among drug-resis-
tant bacteria may be helpful for the development 
of novel therapeutic approaches. MazEF asso-
ciated genes, especially toxin-encoding genes, 
are a potential target for the treatment of drug 
resistant and latent TB infections alongside an-
tibiotic therapy.
Limitations
In the present study, investigation of the stud-
ied genes (mazE3, mazF3, mazE6 and mazF6) and 
other MazEF associated genes (mazE5, mazF5, 
mazE9, and mazF9) in various conditions (i.e. 
presence of several stresses or antibiotics) was 
required.
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